Bactiguard Holding
70.2 SEK 0%Be the first to follow this company
Bactiguard is a global MedTech company that prevent infections related to medical devices. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation. Bactiguard operates through license partnerships with MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard has its headquarters in Stockholm.
Revenue
201.55M
EBIT %
-65.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BACTI B
Daily low / high price
67.8 / 70.2
SEK
Market cap
2.46B SEK
Turnover
90.88K SEK
Volume
1.3K
Latest videos
Financial calendar
Interim report
2024-07-16
Interim report
2024-10-24
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
TomBact AB | 18.4 % | 34.4 % |
GIDL Invest AB | 17.6 % | 34.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
![Bactiguard, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/9bf8e469-7f16-4a09-85ef-dfb0d9c9f195.png)
Bactiguard, Audiocast with teleconference, Q2'24
Finansinspektionen: Korrigering flaggningsmeddelande i Bactiguard Holding AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Finansinspektionen: Flaggningsmeddelande i Bactiguard Holding AB
Finansinspektionen: Flaggningsmeddelande i Bactiguard Holding AB
Bactiguard Holding AB (publ): Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting
Bactiguard Holding AB (publ): Kommuniké från Bactiguard Holding AB:s (publ) årsstämma
Carnegie Commissioned Research: Bactiguard: Sales need to pick up for the stock to move
![Bactiguard, Audiocast with teleconference, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/2f779307-e5e8-4706-8b37-656078037ee8.png)